AATB is excited to invite all AATB members to participate in our Capitol Hill Fly-In on February 25, 2026. This event is a significant opportunity to engage directly with policymakers and advocate for the future of tissue donation. 

Take your career to the next level! The 2025 Emerging Leaders Program is your chance to build leadership skills, gain practical tools, and connect with peers who are shaping the future of the tissue community. Over two-and-a-half-day dynamic days, you’ll walk away with fresh insights and the confidence to lead with impact. Only a few spots remain, reserve yours before it’s too late!

The AATB Grant Program supports innovative research that advances the science and practice of allograft tissue banking. We're looking for hypothesis-driven projects that explore areas such as tissue recovery, processing standards, clinical outcomes, and comparisons between allograft and non-allograft materials. Applicants may come from academic institutions, medical centers, or the allograft tissue industry are all eligible to apply. Grants provide up to $100,000 in total funding for projects lasting up to 12 months. Letters of Intent are due by December 31, 2025. Learn more about eligibility, key dates, and how to apply.

Phys.org
Researchers at ETH Zurich successfully 3D-printed complex muscle tissue in microgravity using a novel biofabrication system, paving the way for realistic disease models and drug testing in space.

ScienceDaily
Flatworm stem cells defy conventional biology by responding to long-distance signals rather than nearby cells, revealing a new model for regeneration that could transform human healing and tissue repair.

Bioengineer.org
Researchers identified Thiorphan as a promising drug for spinal cord injury treatment by using bioinformatics to match regenerative gene expression patterns, demonstrating its effectiveness in both human neural cells and animal models.

BBC Science Focus
Scientists are on the brink of enabling scarless healing in adults by targeting specific fibroblasts and tension-sensing molecules, inspired by the way wounds heal perfectly in the womb.

Genetic Engineering & Biotechnology News
Cyclin A2 gene therapy has been shown to safely induce cell division in adult human heart cells, offering a promising alternative to heart transplants by enabling cardiac regeneration.

Are you due for CTBS recertification? Join us November 12, for “2025 CTB Recertification Process Review.” This session will walk you through CEU requirements, recertification dues, and step-by-step guidance on navigating the AATB Portal. Don’t miss this opportunity to stay on top of your certification requirements and ensure a smooth recertification experience.
Target Audience: This webinar is designed for CTBS professionals seeking recertification by December 31, 2025, or later, and who would like information on certification requirements and the steps needed to successfully complete the recertification process.

Donor families give the ultimate gift, and showing gratitude goes far beyond the donation process. Join us November 19, for “Gratitude in Action: Strengthening Donor Family Connections Through Fundraising and Public Relations.” This session will highlight meaningful ways tissue recovery organizations can give back to their donor families through thoughtful fundraising initiatives and authentic public relations strategies. Don’t miss this opportunity to explore practical ideas to express thanks and amplify donor family voices in impactful and meaningful ways.
Target Audience: This webinar is for tissue recovery professionals, donor family services staff, communications and public relations teams, and organizational leaders seeking to strengthen donor family engagement, enhance community outreach, and develop impactful recognition initiatives.

Great Falls, Montana: Assists the department pathologists (3 physicians) in performing gross surgical exams, frozen sections, fresh specimens e.g. breast margins, and autopsies based on criteria that is documented in operation protocol (only 2 autopsies over last 5 years). Receives, accessions, and accurately processes surgical, autopsy, or diagnostic tissue specimens from various hospital departments and physician offices. Performs other work in clinical Laboratory and Histology as requested. Demonstrates the ability to deal with pressure to meet deadlines, to be accurate, and to handle constantly changing situations. Demonstrates the ability to deal with a variety of people, deal with stressful situations, and handle conflict.

Nashville, Tennessee: The Certified Surgical First Assist performs in the expanded role as a CST First Assistant to the Surgeon, by performing positioning, prepping, and draping of patient, providing hemostasis, providing wound exposure and handling of sutures and tissue under the direction and supervision of the operating surgeon. May perform as a Surgical Technologist when not First Assisting.

Seattle, Washington: This is a terrific opportunity within the Veatch lab for a highly motivated full-time Research Technician I/II to join our team to help drive translational projects forward towards clinical applications by performing bench-level experiments in support of work in T cell engineering and testing of new therapeutic ideas in mouse models. The ideal candidate will be able to work as part of a team as well as independently to follow established protocols. The ideal candidate will have experience working with mammalian cell culture, mouse models of cancer, molecular biology techniques, and flow cytometry.